By proceeding, you agree to our Terms of Use and Privacy Policy.
CosmosID provides an end-to-end microbiome platform and award-winning metagenomics services.
21-23 June 2022
The 7th Microbiome Movement - Drug Development Summit?returns to Boston at a pivotal time. As the microbiome therapeutic space matures, with more indications being pursued and more companies conducting trials, the focus of this event - now in its 7th
Event Ended
USA
Paid
Boston
16-17 November 2022
The 7th Annual Microbiome Connect: USA 2022 is dedicated to showcasing the leading drug development platforms applying microbes, microbe modulators and microbial-derived components to prevent or treat human diseases or make medical diagnosis.
Phage therapies have shown promise in compassionate use, but limited success of double blind randomised controlled trials has slowed progression through the clinic.
31-02 February 2023
From hypothetical to reality, the first ever approval of a microbiome-based therapy is here and is set to propel the industry forward, expanding across a wide range of diseases.
UK
London
28-30 June 2023
Join the 8th Microbiome Movement Drug Development Summit, an event that brings together top drug developers and technology enablers to advance the field of microbiome drug development. With a focus on cutting-edge science, preclinical and clinical tr
12-14 September 2023
The 6th Microbiome Movement - Skin Health & Dermatology Summit aims to accelerate the development and commercialization of scientifically validated skin microbiome products. With the advancements in tools and technologies that allow for a deeper anal
San Diego